Literature DB >> 12795683

Methods for the exclusion of circoviruses and gammaherpesviruses from pigs.

A W Tucker1, F McNeilly, B Meehan, D Galbraith, P D McArdle, G Allan, C Patience.   

Abstract

The use of porcine tissues is being developed as a means to alleviate the shortage of allogeneic tissues and organs available for transplantation. To reduce the possibility of a microorganism of pigs being inadvertently transferred to the recipient of the xenograft, recommendations have been published on the microbiological specifications for organ source pigs. The porcine circoviruses (PCV1 and PCV2) and porcine lymphotropic herpesviruses (PLHV1 and PLHV2) are two infectious agents of pigs which are considered to be of significance for the microbiological safety of xenotransplantation. To ensure the exclusion of these microorganisms from animals destined for use under clinical conditions, reliable breeding methodologies are required. We investigated the efficiency of established derivation procedures for the removal of PCV and PLHV. In comparison with conventionally reared pigs, caesarian and barrier derived animals showed a markedly reduced prevalence of PCVs and PLHVs. Our results indicate that the derivation of animals free of both of these microorganisms is achievable and will enhance the microbiological safety of xenotransplantation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12795683     DOI: 10.1034/j.1399-3089.2003.02048.x

Source DB:  PubMed          Journal:  Xenotransplantation        ISSN: 0908-665X            Impact factor:   3.907


  13 in total

1.  Determinants of high titer in recombinant porcine endogenous retroviruses.

Authors:  Ian Harrison; Yasuhiro Takeuchi; Birke Bartosch; Jonathan P Stoye
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

2.  Porcine lymphotropic herpesvirus DNA detection in multiple organs of pigs in Brazil.

Authors:  Alais M Dall Agnol; Raquel A Leme; Suelen A Suphoronski; Thalita E S Oliveira; Flávia Possatti; Viviane Saporiti; Selwyn A Headley; Amauri Alcindo Alfieri; Alice Fernandes Alfieri
Journal:  Braz J Microbiol       Date:  2020-07-08       Impact factor: 2.476

3.  Monitoring for presence of potentially xenotic viruses in recipients of pig islet xenotransplantation.

Authors:  O Garkavenko; M C Croxson; M Irgang; A Karlas; J Denner; R B Elliott
Journal:  J Clin Microbiol       Date:  2004-11       Impact factor: 5.948

Review 4.  Infection barriers to successful xenotransplantation focusing on porcine endogenous retroviruses.

Authors:  Joachim Denner; Ralf R Tönjes
Journal:  Clin Microbiol Rev       Date:  2012-04       Impact factor: 26.132

5.  Absence of replication-competent human-tropic porcine endogenous retroviruses in the germ line DNA of inbred miniature Swine.

Authors:  Linda Scobie; Samantha Taylor; James C Wood; Kristen M Suling; Gary Quinn; Sharon Meikle; Clive Patience; Henk-Jan Schuurman; David E Onions
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

6.  Antibody Cross-Reactivity between Porcine Cytomegalovirus (PCMV) and Human Herpesvirus-6 (HHV-6).

Authors:  Uwe Fiebig; Angela Holzer; Daniel Ivanusic; Elena Plotzki; Hartmut Hengel; Frank Neipel; Joachim Denner
Journal:  Viruses       Date:  2017-10-28       Impact factor: 5.048

7.  The porcine virome and xenotransplantation.

Authors:  Joachim Denner
Journal:  Virol J       Date:  2017-09-06       Impact factor: 4.099

8.  Xenotransplantation panel for the detection of infectious agents in pigs.

Authors:  Caroll B Hartline; Ra'Shun L Conner; Scott H James; Jennifer Potter; Edward Gray; Jose Estrada; Mathew Tector; A Joseph Tector; Mark N Prichard
Journal:  Xenotransplantation       Date:  2018-07       Impact factor: 3.907

Review 9.  Preventing transfer of infectious agents.

Authors:  Joachim Denner; Nicolas J Mueller
Journal:  Int J Surg       Date:  2015-08-24       Impact factor: 6.071

Review 10.  Porcine Lymphotropic Herpesviruses (PLHVs) and Xenotranplantation.

Authors:  Joachim Denner
Journal:  Viruses       Date:  2021-06-04       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.